Notices

Revision of notice of chemicals under consideration for possible listing via administrative mechanisms: withdrawal of Premarin (CAS No. 12126-59-9) from consideration.

Final determination on the petition to reconsider the listing of mercury and mercury compounds  as known to the State to cause reproductive toxicity.

Clarification of ongoing work at OEHHA to foster consistency and harmonization of risk assessment activities across all Cal/EPA

Start of 60 day comment period for the request for information on the reproductive and developmental toxicity of mercury and mercury compounds (excluding methyl mercury).

Request for information on the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Trimetrexate Glucuronate, Paclitaxel,
Quazepam, Nitrobenzene, Leuprolide Acetate, Ganciclovir Sodium, Goserelin Acetate, Estropipate, Ethionamide, Atenolol, Amiodarone Hydrochloride, C.I. Direct Blue 15, 3,7-Dinitrofluoranthene, 3,9-Dinitrofluoranthene, 1-Amino-2,4-dibromoanthraquinone, C.I. Direct Blue 218, Premarin

Request for information on the reproductive and developmental toxicity of mercury and mercury compounds (excluding methyl mercury), chemicals under reconsideration for listing

OEHHA is soliciting information which may be relevant to the evaluation of the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Tr

Notice of intent to list nine chemicals via the authoritative bodies mechanism or the formally required mechanism as known to the state to cause cancer or reproductive toxicity: Nitromethane, Tetrafluoroethylene, Vinyl fluoride, Spironolactone, Stanozolol, Clarithromycin, Dihydroergotamine mesylate, Hydroxyurea, Oxymetholone

In a notice dated September 27, 1996, OEHHA announced that these chemicals were under consideration for listing based on a review of information indicating that the chemicals may meet the criteria

Notice of postponement of prioritization of carbamazepine and progesterone for possible consideration by the Developmental and Reproductive Toxicant Identification Committee.

Meeting of the Developmental and Reproductive Toxicant Identification Committee to consider listing inorganic arsenic and cadmium.

Request for information on chemicals under consideration for possible listing as known to the State to cause cancer: 5-chloro-ortho-toluidine and its hydrochloride (CASRN: 95-79-4); quinoline (CASRN: 91-22-5); 2,4,5-trimethylaniline and its hydrochloride (CASRN: 137-17-7).

Comment Period - Request for Information on Chemicals to be Considered by the Carcinogen Identification Committee

Announcement of Wednesday, December 4, 1996 meeting of the Developmental and Reproductive Toxicant Identification Committee to consider inorganic arsenic, cadmium, mechanisms for removing chemicals from the Proposition 65 list, and prioritization.

Notice of meeting of the Developmental and Reproductive Toxicant (DART) Identification Committee and draft agenda. Chemicals to be reviewed include inorganic arsenic and cadmium.

This final statement of reasons sets forth the reasons for the repeal of Section 12713 (Exposure to Foods, Drugs, Cosmetics, and Medical Devices) and the amendment to Section 12701 (General), and responds to the objections and recommendations submitted regarding these actions. 

The purpose of this regulation is to provide "safe harbor" no significant risk levels for an additional 140 chemicals, below which the Act does not apply. 

This regulation adopts "no significant risk" levels for Hexachlorodibenzodioxin (HCDD) of 0.0002 microgram per day and 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) of 0.000005 microgram per day. 

The purpose of this regulation is to provide "safe harbor" no significant risk levels for dichloromethane (methylene chloride), trichloroethylene, and vinyl chloride.

This regulation adopts "no significant risk" levels in Section 12705, subsection (b), for the following chemicals: Arsenic, Butylated hydroxyanisole, Cadmium, and Chromium (hexavalent compounds).